Table 2 Hepatitis C treatment outcomes, overall and by setting, July 2020 – July 2022
Setting | Diagnosed chronic hepatitis C, n | Treatment start, n (%) | Treatment completion, n (%) | SVR, n (%) |
|---|---|---|---|---|
NSP | 30 | 28/30 (93) | 25/30 (83) | 11/30 (37) |
AOD | 18 | 17/18 (94) | 15/18 (83) | 10/18 (56) |
MHS | 14 | 14/14 (100) | 12/14 (86) | 11/14 (79) |
Othera | 13 | 12/13 (92) | 10/13 (77) | 7/13 (54) |
Total | 75 | 71/75 (95) | 62/75 (83) | 39/75 (52) |